Systemic treatment for metastatic castrate resistant prostate cancer: Does seqence matter? - Andrews - 20....

Abstract Background Optimal sequencing of systemic therapy in the management for metastatic castration resistant prostate cancer (mCRPC) remains poorly elucidated. The CHAARTED and STAMPEDE studies...

Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prosta....

in castration-resistant prostate cancer (CRPC). Secondary... before treatment and monthly thereafter. Patients were... with metastatic breast, prostate, and colorectal cancers (8–15)...

Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survi....

This final analysis confirms that abiraterone acetate significantly prolongs overall survival in patients with metastatic castration-resistant prostate cancer who have progressed after docetaxel tr...

Prostate Cancer: Types of Treatment | Cancer.Net

Prostate Cancer: Types of Treatment Approved by the Cancer.Net Editorial Board, 12/2022 ON THIS PAGE: You will learn about the different types of treatments doctors use for people with...

NAVER 학술정보 > Circulating tumor cells predict survival benefit from treatment in metastatic castration....

저자 : Johann S de Bono, Howard I Scher, R Bruce Montgomery, Christopher Parker, M Craig Miller, Henk Tissing, Gerald V Doyle, Leon W W M Terstappen, Kenneth J Pienta, Derek Raghavan, 학술지정보 : CLINICAL CANCER RESEARCH · 6302p ~ 6311p · ISSN 1078-0432 · E-ISSN 1557-3265, 발행정보 : Medline · 2008년, 피인용횟수 : 2,054, 자료제공처 : MEDLINE®/PubMed® · Crossref, DOI : 10.1158/1078-0432.CCR-08-0872, 주제분야 : 의약학 > 방사선종양학 , 의약학 > 내과학 , 의약학 > 약학, 키워드 ...

Profile of apalutamide in the treatment of metastatic castration-resistant prostate cancer: evidence to d....

facing metastatic castration-resistant prostate cancer (CRPC). More recently, efforts have been directed at trying to effect change at earlier phases of the disease. Apalutamide (ARN-509)...

Comparison of Systemic Treatments for Metastatic Castration-Sensitive Prostate Cancer A Systematic Review....

Comparison of Systemic Treatments for Metastatic Castration-Sensitive Prostate Cancer A Systematic Review and Network Meta-analysis

Effectiveness and tolerability of targeted drugs for the treatment of metastatic - Merck

Effectiveness and tolerability of targeted drugs for the treatment of metastatic castration-resistant prostate cancer: a network meta-analysis of randomized controlled trials. by Yongquan Wang, Hen...

Visceral disease in castration-resistant prostate cancer

Metastatic involvement of the viscera in men with advanced castration-resistant prostate cancer (CRPC) has been poorly characterised to date. In 359 CRPC patients treated between June 2003 and Dece...

Enzalutamide for the treatment of metastatic castration-resistant prostate cancer

In recent years, several nonhormonal and hormonal agents, including enzalutamide, have been approved for the treatment of metastatic castration-resistant prostate cancer (CRPC) on the basis of impr...